TMEM45B and osteosarcoma: The silencing of TMEM45B in the U2OS cell line reduced the expression of β-catenin, cyclin D1, and c-Myc, suggesting that TMEM45B favors the osteosarcoma progression through regulation of the Wnt signaling pathway (34).